Study of FMT Combined With Nivolumab in Gastric Cancer

Summary

This study is a single-arm, single center study. The purpose of this study is to evaluate the efficacy and safety of FMT capsules XBI-302 combined with Nivolumab in the treatment of anti-PD-1/L1 resistant gastric cancer.

Timeline

Start

2021-10

Primary completion

2023-10

Completion

2023-11

Drugs

Indications